Cargando…
Effects of Celecoxib and Ly117018 Combination on Human Breast Cancer Cells in Vitro
Activation and signalling of estrogen receptor (ER) and COX-2 represent two important pathways in breast cancer cell regulation. Activation of either pathway is associated with breast cancer cell proliferation and eventually malignant progression. Raloxifene analogue, Ly117018, a selective estrogen...
Autores principales: | Baumann, Klaus H., Klusmeier, Elmar, Eggemann, Isabel, Reinartz, Silke, Almeroth, Achim, Kalder, Mathias, Wagner, Uwe |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086307/ https://www.ncbi.nlm.nih.gov/pubmed/21556247 |
Ejemplares similares
-
Tamoxifen and the Rafoxifene analog LY117018: their effects on arachidonic acid release from cells in culture and on prostaglandin I(2 )production by rat liver cells
por: Levine, Lawrence
Publicado: (2004) -
LY3127760, a Selective Prostaglandin E4 (EP4) Receptor Antagonist, and Celecoxib: A Comparison of Pharmacological Profiles
por: Jin, Yan, et al.
Publicado: (2017) -
Valid comparisons and decisions based on clinical registers and population based cohort studies: assessing the accuracy, completeness and epidemiological relevance of a breast cancer query database
por: Jacke, Christian Olaf, et al.
Publicado: (2012) -
Investigating the effect of vandetanib and celecoxib combination on angiogenesis
por: Qadir, Abdul, et al.
Publicado: (2023) -
Cytokinesis-block micronucleus assay of celecoxib and celecoxib derivatives
por: Reimann, Hauke, et al.
Publicado: (2020)